Stock listing

GUBRA Stock Price, News, Filings & Events — Gubra A/s

Selected listing: GUBRA · OMXCOP · DKK · DK

This page tracks Gubra A/s's GUBRA:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GUBRA:OMXCOP. GUBRA:OMXCOP is the stock-level entry point for investors researching Gubra A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gubra A/S is a public company listed on the Danish market under the ticker GUBRA. The company has a market capitalization of approximately 876.4 million Danish kroner. Gubra focuses on developing innovative therapies for metabolic diseases, emphasizing research and development in this field.

GUBRA:OMXCOPDKKDKUpdated August 28, 2026
Gubra A/s logo
Ticker
GUBRA:OMXCOP
Asset type
Stock
Market cap
$1.00B
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
OMXCOP
Currency
DKK

Gubra A/s GUBRA:OMXCOP stock context

This page tracks Gubra A/s's GUBRA:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GUBRA:OMXCOP. GUBRA:OMXCOP is the stock-level entry point for investors researching Gubra A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gubra A/S is a public company listed on the Danish market under the ticker GUBRA. The company has a market capitalization of approximately 876.4 million Danish kroner. Gubra focuses on developing innovative therapies for metabolic diseases, emphasizing research and development in this field.

Latest news from Gubra A/s

All Gubra A/s news →

Gubra A/s earnings calls

Research Gubra A/s

Alternate listings